Drawing for 6A

USPTO serial 98735252

6A

Reviewed by CopyMark Law Group

Reg. 7855937Status 700Registered
Filing date
Status date
Registration date
Jul 8, 2025
Examiner
AVENT, TEAGUE A
Law office
TMO LAW OFFICE 126

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with 6A?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARGARET M. POWERS

MARGARET M. POWERS SHAY GLENN LLP155 Bovet Road, Suite 710San Mateo, CA 94402United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for accessing information in the field of medicine and pharmaceutical research and development services; downloadable computer software used to analyse medical research dataACTIVE—
035Business consultancy and advisory services; provision of business information and business advisory services to laboratory networks and diagnostic and pharmaceutical companies; compilation of information, statistics and data into databases in the field of medicine and pharmaceutical testing, research and development services; business data analysis; business advisory and consultancy services relating to business intelligence and industry research; compilation of information into computer databasesACTIVE—
042Research and development of medicines and pharmaceutical products; research and development in the field of diagnostic preparations; provision of scientific information and data relating to medical and veterinary research and development; technical medical and pharmaceutical data analysis services for research and development purposes for others; providing non-downloadable software as software as a service (SAAS) services featuring software for business data management, data analysis, data manipulation, and medicine and pharmaceutical testing, and accessing information in the field of research and development services; providing non-downloadable software as software as a service (SAAS) services featuring software for business data management and visualisation, for generating reports, charts and dashboards in the field of business information; providing non-downloadable software platform as a service (PAAS) services featuring computer software platforms for business data management, data analysis, data manipulation, and medicine and pharmaceutical testing, and accessing information in the field of research and development services; scientific information, advice and consultancy in relation to all the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 8, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 20, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 20, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 18, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 18, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 18, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 7, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 3, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 3, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 3, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 3, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 18, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2025DOCKASSIGNED TO EXAMINER—
Mar 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 5, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance